{
    "organizations": [],
    "uuid": "51f24dee91bbbc7e7f4912ccfba6b06617a0d76d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aequus-and-camargo-to-meet-fda-to/brief-aequus-and-camargo-to-meet-fda-to-advance-anti-nausea-patch-idUSFWN1PQ0ZU",
    "ord_in_thread": 0,
    "title": "BRIEF-Aequus And Camargo To Meet FDA To Advance Anti-Nausea Patch",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 31 (Reuters) - Aequus Pharmaceuticals Inc:\n* AEQUUS AND CAMARGO PREPARE FOR MEETING WITH FDA TO ADVANCE ANTI-NAUSEA PATCH\n* AEQUUS PHARMACEUTICALS - CO WILL WORK WITH CAMARGO PHARMACEUTICAL TO PREPARE FOR PRE-IND MEETING WITH U.S. FDA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-31T21:49:00.000+02:00",
    "crawled": "2018-02-01T15:22:40.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "aequus",
        "pharmaceutical",
        "inc",
        "aequus",
        "camargo",
        "prepare",
        "meeting",
        "fda",
        "advance",
        "patch",
        "aequus",
        "pharmaceutical",
        "co",
        "work",
        "camargo",
        "pharmaceutical",
        "prepare",
        "meeting",
        "fda",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}